methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol]
- RxCUI
- 207193
- RxNorm name
- methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol]
- Display name
- SOLU-Medrol (Injectable)
- Full name
- methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol]
- Term type
- SBD
- Status
- Active
- Strength
- 62.5 mg/ml
- Dose form
- Sol
- Route
- Injectable
- Updated
- 2026-11-08 10:18:24
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| methylprednisolone sodium succinate | 62.5 MG / 1 ML | methylprednisolone | methylprednisolone |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injectable Solution | 316949 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| methylprednisolone | 6902 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | SOLU-Medrol 62.5 MG/ML Injectable Solution | 1 | NAMES |
| RxNorm Name | methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 207193 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0009-0698-01 | 0009-0698 | SOLU-MEDROL methylprednisolone sodium succinate | Pharmacia & Upjohn Company LLC | NDA011856 |
| 0009-0698-02 | 0009-0698 | SOLU-MEDROL methylprednisolone sodium succinate | Pharmacia & Upjohn Company LLC | NDA011856 |
| 0009-0758-01 | 0009-0758 | SOLU-MEDROL methylprednisolone sodium succinate | Pharmacia & Upjohn Company LLC | NDA011856 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | 7271310c-7764-4812-aa30-a5e90987c7a9 | 2026-06-25 | Warnings, Adverse reactions | 0009-0698-02 0009-0698 00009069802 207193 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | cd99be87-c8d9-48d6-a8e5-e081052e3f19 | 2025-12-02 | Warnings, Adverse reactions | 0009-0758-01 0009-0698-01 0009-0758 0009-0698 00009004727 00009004726 00009004722 00009004725 00009075801 00009069801 207193 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cd99be87-c8d9-48d6-a8e5-e081052e3f19 | SOLU-Medrol 62.5 MG/ML Injectable Solution [PSN] · methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol] [SBD] · Solu-Medrol (as methylprednisolone sodium succinate) 62.5 MG/ML Injectable Solution [SY] · Solu-Medrol 62.5 MG/ML Injectable Solution [SY] | 4 | 35 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20251202 |
| 7271310c-7764-4812-aa30-a5e90987c7a9 | SOLU-Medrol 62.5 MG/ML Injectable Solution [PSN] · methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol] [SBD] · Solu-Medrol (as methylprednisolone sodium succinate) 62.5 MG/ML Injectable Solution [SY] · Solu-Medrol 62.5 MG/ML Injectable Solution [SY] | 4 | 11 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | 20251203 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 7271310c-7764-4812-aa30-a5e90987c7a9 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | Pharmacia & Upjohn Company LLC | 20260625 |
| 7271310c-7764-4812-aa30-a5e90987c7a9 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | Pharmacia & Upjohn Company LLC | 20251203 |
| cd99be87-c8d9-48d6-a8e5-e081052e3f19 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | Pharmacia & Upjohn Company LLC | 20251202 |
| 7271310c-7764-4812-aa30-a5e90987c7a9 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | Pharmacia & Upjohn Company LLC | 20251125 |
| cd99be87-c8d9-48d6-a8e5-e081052e3f19 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | Pharmacia & Upjohn Company LLC | 20251124 |
| 7271310c-7764-4812-aa30-a5e90987c7a9 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | Pharmacia & Upjohn Company LLC | 20250730 |
| cd99be87-c8d9-48d6-a8e5-e081052e3f19 | SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) | Pharmacia & Upjohn Company LLC | 20250513 |
| 1ae6fb26-76b3-40a2-938e-0d2fb48a08f8 | National Council for Prescription Drug Programs | 20130502 | |
| 1d279bcb-0bbb-4c7c-a077-0b19a114c75a | National Council for Prescription Drug Programs | 20130213 | |
| 7bfba518-8122-45f4-8b32-7380abc4a0ef | National Council for Prescription Drug Programs | 20130213 | |
| 7029e370-6384-4c2a-abc3-0c5ef722842b | National Council for Prescription Drug Programs | 20120724 | |
| 8a9fca70-b985-4d56-ab2c-b677f4421450 | National Council for Prescription Drug Programs | 20120724 | |
| a6bb9d8e-775e-414b-a78c-e9be34f72b91 | National Council for Prescription Drug Programs | 20120724 | |
| b2173d6d-279e-4bf1-8c37-2b83881083a4 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D10AA | Corticosteroids, combinations for treatment of acne | ATC1-4 | methylprednisolone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | methylprednisolone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | methylprednisolone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | methylprednisolone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | D008775 | Methylprednisolone | CHEM | has_ingredient | methylprednisolone |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 62.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA011856 |
| NAMES | Prescribable Synonym | SOLU-Medrol 62.5 MG/ML Injectable Solution |
| NAMES | Tallman Synonym | methylPREDNISolone 62.5 MG/ML Injectable Solution [SOLU-Medrol] |
| NAMES | Tallman Synonym | SOLU-Medrol (as methylPREDNISolone sodium succinate) 62.5 MG/ML Injectable Solution |
| NAMES | Tallman Synonym | SOLU-Medrol 62.5 MG/ML Injectable Solution |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |